Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up

Piccart, Martine, Procter, Marion, Fumagalli, Debora · Journal of Clinical Oncology · 2021